amoxicillin/clavulanic acid (LP-001)
/ Kaizen Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
February 05, 2025
A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection
(clinicaltrials.gov)
- P1 | N=39 | Completed | Sponsor: Kaizen Bioscience Co. | Recruiting ➔ Completed | N=24 ➔ 39 | Trial completion date: Jun 2024 ➔ Dec 2024 | Trial primary completion date: Jun 2024 ➔ Dec 2024
Enrollment change • Trial completion • Trial completion date • Trial primary completion date • Infectious Disease • Pediatrics
February 07, 2024
A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: Kaizen Bioscience Co. | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Pediatrics
October 18, 2022
A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Kaizen Bioscience Co.
New P1 trial • Infectious Disease • Pediatrics
1 to 3
Of
3
Go to page
1